1er novembre, 2012by Mario1 November 201228 February 2013Alethia Biothérapeutiques conclut un financement de 4.7 M $ pour le développement de son inhibiteur de résorption osseuse Alethia 121101 FR Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.